CXCL10 can recruit NK cells to tumor site and activate NK cells to kill cancer cells (Nagarsheth et al., 2017), and it has been reported strongly produced in tumor compared with the adjacent tissue in EC (Degos et al., 2019). The gene discussed is CXCL10; the disease is cancer.